Roche in Cancer Drug Setback

Roche Holding said an independent committee recommended the drug giant cancel a late-stage test of a lung cancer treatment because the therapy failed to produce meaningful results.



from WSJ.com: US Business http://ift.tt/1pSVvEj

via IFTTT